RxSight, Inc. RXST Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$15.88M-93.9% | -$9.15M-54.1% | -$9.82M-54.9% | -$11.79M-93.9% | -$8.19M+10.0% | ||
| $834K+7.5% | $851K+65.2% | $854K-24.6% | $785K-3.3% | $776K-30.4% | ||
| $7.95M+11.3% | $7.82M+7.3% | $8.11M+23.7% | $8.55M+40.0% | $7.14M+52.0% | ||
| -$936K-201% | -$788K-117% | -$3.91M— | -$2.89M-169% | $928K-26.9% | ||
| $3.37M+111% | $3.23M+690% | $3.96M+65.1% | $2.71M+239% | $1.6M+14.9% | ||
| $1.58M-29.2% | $2.2M+1,800% | -$86K-310% | -$3.72M— | $2.23M+89.3% | ||
| -$1.26M+79.6% | —— | —— | —— | -$6.16M-64.9% | ||
| -$120K+52.8% | —— | -$322K-81.9% | -$1.49M-1,331% | -$254K+55.4% | ||
| $0-100% | —— | $0-100% | -$9K-213% | $9K-64.0% | ||
| —— | $0— | $0— | $0— | $0— | ||
| -$10.89M-23.3% | -$1.12M+73.8% | -$1.19M— | -$4.38M-8.7% | -$8.83M+5.1% | ||
| $759K+32.0% | $1.14M+34.2% | $581K-47.3% | $1.54M+0.9% | $575K-70.8% | ||
| $100.39M+160% | $98.48M+86.4% | $68.42M-11.3% | $33.81M-78.8% | $38.57M-19.2% | ||
| $110M+83.3% | $90M+63.6% | $60M-13.0% | $50M+11.1% | $60M-18.9% | ||
| $8.85M-57.6% | —— | —— | $14.65M+113% | $20.86M-14.1% | ||
| $144K-79.3% | $1.06M-64.7% | $131K-96.6% | $2.07M-46.1% | $696K-93.1% | ||
| $7K-46.2% | —— | $19K+72.7% | $3K-72.7% | $13K-51.9% | ||
| —— | $0— | $0+100% | $0— | $0— | ||
| -$336K+54.3% | $1.06M-64.3% | —— | $2.07M-98.1% | -$735K-109% | ||
| $3K-50.0% | —— | —— | $14K+1,500% | $6K+300% | ||
| -$2.38M-121% | —— | —— | $12.36M— | $11.29M-50.8% | ||
| $0-100% | —— | —— | $67K+179% | $3K— | ||
| $1.85M-23.1% | $1.83M-30.3% | $2.14M-22.6% | $2.13M+2.7% | $2.41M+60.2% | ||
| -$1.26M+79.6% | —— | —— | —— | -$6.16M-64.9% | ||
| -$120K+52.8% | —— | -$322K-81.9% | -$1.49M-1,331% | -$254K+55.4% | ||
| $60K+93.5% | $616K+768% | $66K-60.2% | $1.22M+2,077% | $31K-72.1% | ||
| $0-100% | —— | $0-100% | -$9K-213% | $9K-64.0% | ||
| —— | —— | —— | —— | —— | ||
| $0-100% | —— | —— | $11K— | $21K— | ||
| $100.39M+160% | $98.48M+86.4% | $68.42M-11.3% | $33.81M-78.8% | $38.57M-19.2% | ||
| $110M+83.3% | $90M+63.6% | $60M-13.0% | $50M+11.1% | $60M-18.9% | ||
| $7K-46.2% | —— | $19K+72.7% | $3K-72.7% | $13K-51.9% | ||
| -$473K+66.6% | -$2K— | -$642K+75.6% | $0— | -$1.42M+33.6% | ||
| —— | $0— | $0-100% | —— | —— | ||
| —— | $0— | $0— | —— | —— | ||
| $170K-16.7% | $286K+88.2% | —— | $46K— | $204K-40.5% | ||
| $980K+41.2% | $684K+31.3% | $560K+10.9% | $689K+18.8% | $694K+26.6% | ||
| —— | $0— | $0— | $0— | $0— | ||
| —— | —— | —— | —— | —— | ||
| $0-100% | —— | —— | $67K+179% | $3K— | ||
| -$11.65M-23.8% | -$2.25M+55.9% | -$1.77M-290% | -$5.91M-6.5% | -$9.41M+16.6% | ||
| -$11.65M-23.8% | -$2.25M+55.9% | -$1.77M-290% | -$5.91M-6.5% | -$9.41M+16.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does RxSight, Inc. generate?
- RxSight, Inc. (RXST) generated -$17.6M in operating cash flow over the trailing twelve months.
- What is RxSight, Inc.'s free cash flow?
- After $4.0M of capital expenditures, RxSight, Inc.'s free cash flow was -$21.6M over the trailing twelve months, down 5.2% year over year.
- Where does RxSight, Inc.'s cash flow data come from?
- Every line is extracted from RxSight, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
